Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.99 USD | +0.20% | -8.94% | -11.68% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
Financials (USD)
Sales 2024 * | 25.7M | Sales 2025 * | 20.24M | Capitalization | 344M |
---|---|---|---|---|---|
Net income 2024 * | -116M | Net income 2025 * | -149M | EV / Sales 2024 * | 1.82 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 286M | EV / Sales 2025 * | 2.86 x |
P/E ratio 2024 * |
-3.11
x | P/E ratio 2025 * |
-2.62
x | Employees | 145 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.26% |
Latest transcript on C4 Therapeutics, Inc.
1 day | +0.20% | ||
1 week | -8.94% | ||
Current month | -0.20% | ||
1 month | -20.79% | ||
3 months | -54.55% | ||
6 months | +206.13% | ||
Current year | -11.68% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Kendra Adams
DFI | Director of Finance/CFO | 47 | 20-11-19 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 15-11-30 |
Glenn Dubin
BRD | Director/Board Member | 67 | 21-03-11 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5 | +0.40% | 1,139,771 |
24-05-30 | 4.98 | -0.20% | 1,464,293 |
24-05-29 | 4.99 | -6.90% | 1,550,087 |
24-05-28 | 5.36 | -2.19% | 1,185,566 |
24-05-24 | 5.48 | -1.62% | 773,892 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.68% | 343M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CCCC Stock